Pain and Sleep Disturbances in Children Living Beyond Cancer: A Case-Control Study
The Co-Morbidity of Pain and Sleep Disturbances in Children Living Beyond Cancer: A Case-Control Study
1 other identifier
observational
76
1 country
1
Brief Summary
Children living beyond cancer (CBC) represent a unique and growing population of young people in need of long-term clinical support. Studies suggest that 11-44% of CBC experience chronic pain, negatively impacting a wide range of child biopsychosocial outcomes and creating high financial burden for their families and society. Often comorbid with pain, one of the most chronic and disturbing side effects reported by CBC are sleep disturbances, and in particular, difficulties initiating and maintaining sleep. Indeed, \>50% of CBC report some form of sleep disturbance even 9 to 15 years after the cancer diagnosis. Much attention has been paid to sleep and pain as independent constructs within pediatric oncology, yet Belgian data is lacking. Additionally, little is known about how these domains interact with one another and subsequent indications for prevention and intervention. Although evidence shows an interrelationship between pain and sleep in adult and pediatric populations, this interrelationship is understudied in childhood cancer patients and CBC. (Chronic) pain may serve as a modifiable target for interventions to improve sleep quality and vice versa, and understanding this relationship is crucial for providing comprehensive care to CBC. Therefore, this cross-sectional case-control study aims to explore the differences in pain and sleep disturbances in CBC compared to healthy age- and sex-matched healthy controls, as well as the interrelationship between both outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedFirst Posted
Study publicly available on registry
August 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
August 13, 2025
August 1, 2025
10 months
June 26, 2025
August 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Activity limitations due to pain
Measured with the Child Activity Limitations Interview (CALI) - 9 (parent-report version for the 6-7 year-olds; self-report version for the 8-12 year-olds)
Baseline about the past 14 days + 14 days following baseline in daily sleep diary
Sleep disturbances
Assessed with the PROMIS Parent Proxy Item Bank v1.0 - Sleep Disturbance - Short Form 8a parent-report for the 6-7 year olds and PROMIS Pediatric Item Bank v1.0 - Sleep Disturbance - Short Form 8a for the 8-12 year-olds. Additionally, this outcome measure is assessed with the Children's Sleep Habits Questionnaire (CSHQ) (parent-report for all ages).
Baseline
Secondary Outcomes (13)
Pain severity
Baseline
Pain coping
Baseline
Pain reporting and assessment during follow-up care
Baseline
Health-related quality of life
Baseline
Fatigue
Baseline
- +8 more secondary outcomes
Other Outcomes (1)
Information about prior night's sleep pattern and day
From baseline to 14 days later
Study Arms (2)
children living beyond cancer (CBC)
healthy controls
age- and sex-matched healthy controls
Interventions
Baseline questionnaires (measuring socio-demographic and health-related information, as well as most outcome measures), followed by 2 weeks of actigraphy measurement and daily sleep diary.
Eligibility Criteria
Children living beyond cancer (6-12 years old) and age- and sex-matched healthy controls, together with one of their parents.
You may qualify if:
- CBC: 1) current age 6-12yo; 2) history of any cancer diagnosis; 3) ≤ 5y post- treatment completion; 4) ≥ 3 months since last cancer treatment (since pain and insomnia during treatment can be directly related to therapy and recover spontaneously); 5) fluent Dutch speaker and reader (age-dependent)
- Healthy controls (age- and sex-matched): 1) current age 6-12yo; 2) no history of cancer ; 3) fluent Dutch speaker and reader (age-dependent)
- Parents: 1) fluent Dutch speaker and reader
You may not qualify if:
- CBC: 1) receiving palliative therapy; 2) psychiatric disorder; 3) severe intellectual disability
- Healthy controls: 1) history of cancer; 2) psychiatric disorder; 3) severe intellectual disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vrije Universiteit Brussellead
- Research Foundation Flanderscollaborator
Study Sites (1)
Vrije Universiteit Brussel
Jette, Brussels Capital, 1090, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emma Rheel, PhD
Vrije Universiteit Brussel
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
June 26, 2025
First Posted
August 13, 2025
Study Start
August 1, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
August 13, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Within one year following the end of the study, for 10 years.
- Access Criteria
- Closed access (only on reasonable request)
Data will be documented both at the project level and at the data level: Data level: * In research papers; * Information about variables using labels and variables derivations Project level * Documentation about the authors, background, aims, objectives, and the hypotheses that shape the research * Data collection protocol \& procedures * Project meeting reports Descriptive metadata of data items will be registered in Pure Database with restricted acces (closed access, only on reasonable request). In addition, the raw dataset will include labels in the .xlsx file including variable information providing documentation at the data level. Datasets will be accompanied by a separate word.doc file providing study-level documentation including the field methods used for data collection.